Genomind was founded over a decade ago by Dr. Ronald Dozoretz, affectionately known as Dr. D (April 1935 May 2020). After completing his psychiatric residency at Case Western University Hospital and serving as Lieutenant Commander at the U.S. Naval Hospital in Portsmouth, Virginia, he spent his later years establishing his own psychiatric centers, hospitals and businesses dedicated to advancing the field of psychiatry through meaningful innovation and compassionate patient care. Dr. D was an early adopter of pharmacogenetics (PGx) and he believed genetics could fundamentally change how medicine is prescribed in the field of mental health. Dr. D set out to make that vision a reality by establishing Genomind as one of the first mental health focused pharma-cogenetic testing services. Today, PGx is increasingly recognized as valid and effective tool for the delivery of quality psychiatric care. Genomind committed to honoring his memory by continuing his mission to deliver innovative solutions to help improve patient care for mental health and beyond.
